| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |